IM Cannabis (IMCC) Cost of Revenue (2020 - 2026)
IM Cannabis (IMCC) posted quarterly Cost of Revenue of $5.3 million for Q1 2026, down 16.08% year-over-year from $6.3 million in Q1 2025, and down 52.68% quarter-over-quarter from $11.2 million in Q4 2025.
IM Cannabis (IMCC) Cost of Revenue (2020 - 2026) Analysis & Trends
IM Cannabis' Cost of Revenue history runs 7 years deep, the most recent figure standing at $5.3 million for Q1 2026.
- In Q1 2026, Cost of Revenue fell 16.08% year-over-year to $5.3 million; the TTM figure through Mar 2026 stood at $31.3 million (down 2.25% YoY), while the FY2025 annual figure was $32.3 million, down 2.98% from the prior year.
- Cost of Revenue for Q1 2026 stood at $5.3 million, down from $11.2 million in the prior quarter.
- The five-year high for Cost of Revenue was $11.2 million in Q4 2025, with the low at $5.3 million in Q1 2026.
- The 5-year median for Cost of Revenue is $7.6 million (2024), against an average of $7.8 million.
- The sharpest annual moves came in 2022 and 2025: Cost of Revenue surged 139.3% in 2022, then plunged 34.19% in 2025.
- IM Cannabis' Cost of Revenue stood at $8.6 million in 2022, then fell by 18.13% to $7.0 million in 2023, then grew by 8.36% to $7.6 million in 2024, then soared by 46.68% to $11.2 million in 2025, then slumped by 52.68% to $5.3 million in 2026.
- Business Quant data shows IMCC's Cost of Revenue at $5.3 million in Q1 2026, $11.2 million in Q4 2025, and $8.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 1.99 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 673.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 2.55 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 99.50 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 2.30 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 23.20 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 570.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | IM Cannabis | 554,496.00 | -614,474.17 | 1.09 Mn | 4.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.40 Mn |
| Jun 30, 2026 | 4.40 Mn |
| Mar 31, 2026 | 5.29 Mn |
| Mar 31, 2026 | 5.29 Mn |
| Dec 31, 2025 | 11.19 Mn |
| Dec 31, 2025 | 11.19 Mn |
| Sep 30, 2025 | 8.08 Mn |
| Sep 30, 2025 | 8.08 Mn |
| Jun 30, 2025 | 6.69 Mn |
| Jun 30, 2025 | 6.69 Mn |
| Mar 31, 2025 | 6.31 Mn |
| Mar 31, 2025 | 6.31 Mn |
| Dec 31, 2024 | 7.63 Mn |
| Dec 31, 2024 | 7.63 Mn |
| Sep 30, 2024 | 7.87 Mn |
| Sep 30, 2024 | 7.87 Mn |
| Jun 30, 2024 | 10.17 Mn |
| Jun 30, 2024 | 10.17 Mn |
| Mar 31, 2024 | 7.62 Mn |
| Mar 31, 2024 | 7.62 Mn |